Drug intelligence / Profile preview

Lipiojoint (Terumo)

Development stage
Unknown
Lead developer
Guerbet
Administration
Intra-arterial
01

Overview

Lipiojoint (polyethylene glycol microspheres) is a biocompatible, non-resorbable embolic agent developed by Terumo. It consists of spherical hydrogel particles made from a polyethylene glycol (PEG) backbone. These microspheres are specifically designed for permanent embolization of target vasculature, most notably in genicular artery embolization (GAE) for the treatment of symptomatic knee osteoarthritis. By occluding the small vessels supplying the inflamed synovium, the microspheres reduce hypervascularity and associated inflammatory pain. The PEG-based chemistry provides high compressibility and elasticity, which facilitates smooth delivery through microcatheters and ensures effective distal occlusion. Beyond osteoarthritis, these microspheres are utilized for the embolization of hypervascular tumors and arteriovenous malformations.

Brand names
Lipiojoint
Other names
polyethylene glycol microspheresPEG microspherespolyethylene glycol-based microspheresPEG-MS

Beyond the preview

Go deeper on Lipiojoint (Terumo).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipiojoint (Terumo).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call